← Open Payments lookup

OSCAR GALINDO: Open Payments

NPI 1639325178 · CUDAHY, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,625 in 99 payments from 22 companies in 2025. Trend: 2023 $2,155 · 2024 $2,004 · 2025 $3,625

Food & beverage: $3,625
CompanyPaymentsAmount
Novo Nordisk Inc22$663
Amgen Inc.22$557
AstraZeneca Pharmaceuticals LP9$357
CeQur Corporation1$283
Bayer Healthcare Pharmaceuticals Inc.5$210
Merck Sharp & Dohme LLC7$197
Kowa Pharmaceuticals America, Inc.2$132
VERTEX PHARMACEUTICALS INCORPORATED1$125
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$125
Travere Therapeutics, Inc.1$125

Products named: REPATHA, CeQur Simplicity, Wegovy, OTEZLA, Kerendia, Ozempic, VERQUVO, BREZTRI.

Industry payments across CA — which companies pay providers there.